For the Quarter Ending June 2023

North America:

Carbamazepine prices in North America started on an optimistic note but ended on a pessimistic trend in the second quarter of 2023. The prices followed the market trend in India throughout the quarter, gradually increasing from the previous month until May 2023. This rise in prices was driven by improved demand in the pharmaceutical and healthcare industries, allowing retailers to charge higher prices. Despite the strengthening Consumer Price Index (CPI) in the US, prices for Carbamazepine sharply decreased as June approached. Local demand also saw a sharp decline, and analysts suggested that there was still significant underlying inflation despite falling energy prices.

Asia Pacific:

In the Asia Pacific region, Carbamazepine prices showed a descending pricing sentiment throughout the second quarter of 2023. Prices dropped considerably in April, indicating a positive demand outlook until mid-Q2. However, prices sharply decreased as Q2 ended in June 2023. Carbamazepine consumption increased in the domestic market, with inquiries surging from both domestic and overseas markets. The manufacturing PMI fell in April, but started to recover in May as supply began to decline and production increased. The price trend in May was supported by suppliers and merchants selling their finished goods for higher prices than usual. However, in June, the PMI for India slightly declined, leading to declining purchasing activity and lessened exporting momentum.

Get Real Time Prices of Carbamazepine: https://www.chemanalyst.com/Pricing-data/carbamazepine-1525

Europe:

In the German market, Carbamazepine prices followed a similar trajectory as the Asia Pacific region in the second quarter of 2023. Prices surged at the beginning of Q2 and remained on the higher side until mid-Q2. The availability of downstream Carbamazepine at lower prices from exporting nations like India played a role in supporting the prices. However, as June approached, prices steadily declined, maintaining a balance between demand and supply. The price of raw materials used to produce Carbamazepine has also been falling, contributing to the overall price decline. Geopolitical tensions and rising energy costs have negatively impacted supply chains and economic activity in Germany.


About Us:

ChemAnalyst is an online platform offering a comprehensive range of market analysis and pricing services, as well as up-to-date news and deals from the chemical and petrochemical industry, globally.

Being awarded ‘The Product Innovator of the Year, 2023’, ChemAnalyst is an indispensable tool for navigating the risks of today's ever-changing chemicals market.

The platform helps companies strategize and formulate their chemical procurement by tracking real time prices of more than 400 chemicals in more than 25 countries.

ChemAnalyst also provides market analysis for more than 1000 chemical commodities covering multifaceted parameters including Production, Demand, Supply, Plant Operating Rate, Imports, Exports, and much more. The users will not only be able to analyse historical data but will also get to inspect detailed forecasts for upto 10 years. With access to local field teams, the company provides high-quality, reliable market analysis data for more than 40 countries.